A cost benefit analysis of a virtual overdose monitoring service/mobile overdose response service: the national overdose response service
| dc.contributor.author | Rioux, William | |
| dc.contributor.author | Enns, Benjamin | |
| dc.contributor.author | Jackson, Jennifer | |
| dc.contributor.author | Quereshi, Hena | |
| dc.contributor.author | Irvine, Mike | |
| dc.contributor.author | Ghosh, S. M. | |
| dc.date.accessioned | 2023-10-08T00:03:55Z | |
| dc.date.available | 2023-10-08T00:03:55Z | |
| dc.date.issued | 2023-10-04 | |
| dc.date.updated | 2023-10-08T00:03:55Z | |
| dc.description.abstract | Abstract Background The overdose crisis continues across Canada which calls for novel harm reduction strategies. Previous research indicates that a majority of eHealth solutions are cost-effective however current literature on the cost-benefit of eHealth for harm reduction is sparse. The National Overdose Response Service (NORS) is a Canada-wide telephone-based harm reduction service. Service users can call the phone number and connect to a peer who can virtually monitor the substance use session and dispatch appropriate interventions in the case of overdose. Objectives of the research/project We aim to assess the cost-benefit of NORS by comparing the estimated cost-savings from prevented overdose mortality to the operating costs of the program, alongside healthcare costs associated with its operation. Methods Data around systems costs and operational costs were gathered for our calculations. Our primary outcome was cost-benefit ratios, derived from estimates and models of mortality rates in current literature and value of life lost. We presented our main results across a range of values for costs and the probability of death following an unwitnessed overdose. These values were utilized to calculate cost-benefit ratios and value per dollar spent on service provision by NORS over the length of the program’s operation (December 2020–2022). Results Over the total funded lifespan of the program, and using a Monte Carlo estimate, the benefit-to-cost ratio of the NORS program was 8.59 (1.53–15.28) per dollar spent, depending on estimated mortality rates following unwitnessed overdose and program operation costs. Further, we conservatively estimate that early community-based naloxone intervention results in healthcare system savings of $4470.82 per overdose response. Conclusions We found the NORS program to have a positive benefit-to-cost ratio when the probability of death following an unwitnessed overdose was greater than 5%. NORS and potentially other virtual overdose monitoring services have the potential to be cost-effective solutions for managing the drug poisoning crisis. | |
| dc.identifier.citation | Substance Abuse Treatment, Prevention, and Policy. 2023 Oct 04;18(1):57 | |
| dc.identifier.uri | https://doi.org/10.1186/s13011-023-00565-8 | |
| dc.identifier.uri | https://hdl.handle.net/1880/117361 | |
| dc.identifier.uri | https://doi.org/10.11575/PRISM/42204 | |
| dc.language.rfc3066 | en | |
| dc.rights.holder | BioMed Central Ltd., part of Springer Nature | |
| dc.title | A cost benefit analysis of a virtual overdose monitoring service/mobile overdose response service: the national overdose response service | |
| dc.type | Journal Article |